GlobeNewswire Inc.··NaCue Biopharma Secures $7.5M Milestone from Boehringer Ingelheim Deal
$CBPO secures $7.5M milestone from Boehringer Ingelheim partnership, with $337.5M upside potential as lead compound advances to optimization.
CUEautoimmune diseasesbiopharmaceutical